NUCLEOTIDE NUTRITION LTD Accounts filed on 31-03-2014

NUCLEOTIDE NUTRITION LTD Accounts filed on 31-03-2014


false true true true 2013-04-01 2014-03-31 2014-03-31 true 07803653 2013-04-01 2014-03-31 07803653 2011-10-10 2013-03-31 07803653 2014-03-31 07803653 2013-03-31 07803653 2013-03-31 07803653 2011-10-09 07803653 uk-bus:Director1 2013-04-01 2014-03-31 07803653 uk-bus:Director1 2013-04-01 07803653 uk-bus:Director1 2014-03-31 07803653 uk-bus:CompanySecretary 2013-04-01 2014-03-31 07803653 uk-gaap:OwnedOrFreeholdTangibleFixedAssets 2013-04-01 2014-03-31 07803653 uk-gaap:OwnedOrFreeholdTangibleFixedAssets 2011-10-10 2013-03-31 07803653 uk-gaap:LeasedTangibleFixedAssets 2013-04-01 2014-03-31 07803653 uk-gaap:LeasedTangibleFixedAssets 2011-10-10 2013-03-31 07803653 uk-gaap:NetGoodwill 2013-04-01 2014-03-31 07803653 uk-gaap:NetGoodwill 2011-10-10 2013-03-31 07803653 uk-gaap:IntangibleAssetsOtherThanGoodwill 2013-04-01 2014-03-31 07803653 uk-gaap:IntangibleAssetsOtherThanGoodwill 2011-10-10 2013-03-31 07803653 uk-bus:AllEntityOfficers 2013-04-01 2014-03-31 07803653 uk-bus:AllEntityOfficers 2011-10-10 2013-03-31 07803653 uk-bus:AllOrdinaryShares 2013-04-01 2014-03-31 07803653 uk-bus:AllOrdinaryShares 2014-03-31 07803653 uk-bus:AllOrdinaryShares 2011-10-10 2013-03-31 07803653 uk-bus:AllOrdinaryShares 2013-03-31 07803653 uk-bus:AllPreferenceShares 2013-04-01 2014-03-31 07803653 uk-bus:AllPreferenceShares 2014-03-31 07803653 uk-bus:AllPreferenceShares 2011-10-10 2013-03-31 07803653 uk-bus:AllPreferenceShares 2013-03-31 07803653 uk-gaap:NetGoodwill 2014-03-31 07803653 uk-gaap:NetGoodwill 2013-03-31 07803653 uk-gaap:IntangibleAssetsOtherThanGoodwill 2014-03-31 07803653 uk-gaap:IntangibleAssetsOtherThanGoodwill 2013-03-31 07803653 uk-gaap:LandBuildings 2014-03-31 07803653 uk-gaap:LandBuildings 2013-04-01 2014-03-31 07803653 uk-gaap:LandBuildings 2013-03-31 07803653 uk-gaap:PlantMachinery 2014-03-31 07803653 uk-gaap:PlantMachinery 2013-04-01 2014-03-31 07803653 uk-gaap:PlantMachinery 2013-03-31 07803653 uk-gaap:FixturesFittings 2014-03-31 07803653 uk-gaap:FixturesFittings 2013-04-01 2014-03-31 07803653 uk-gaap:FixturesFittings 2013-03-31 07803653 uk-gaap:MotorVehicles 2014-03-31 07803653 uk-gaap:MotorVehicles 2013-04-01 2014-03-31 07803653 uk-gaap:MotorVehicles 2013-03-31 07803653 uk-gaap:OfficeEquipment 2014-03-31 07803653 uk-gaap:OfficeEquipment 2013-04-01 2014-03-31 07803653 uk-gaap:OfficeEquipment 2013-03-31 07803653 uk-bus:RegisteredOffice 2013-04-01 2014-03-31 07803653 uk-gaap:WithinOneYear 2014-03-31 07803653 uk-gaap:WithinOneYear 2013-03-31 07803653 uk-gaap:AfterOneYear 2014-03-31 07803653 uk-gaap:AfterOneYear 2013-03-31 07803653 uk-gaap:BetweenOneFiveYears 2014-03-31 07803653 uk-gaap:BetweenOneFiveYears 2013-03-31 07803653 uk-gaap:MoreThanFiveYears 2014-03-31 07803653 uk-gaap:MoreThanFiveYears 2013-03-31 iso4217:GBP xbrli:pure xbrli:shares

NUCLEOTIDE NUTRITION LTD




Company Registration Number:
07803653 (England and Wales)



Abbreviated (Unaudited) Accounts



Period of accounts


Start date: 01st April 2013

End date: 31st March 2014

SUBMITTED

NUCLEOTIDE NUTRITION LTD

Company Information
for the Period Ended
31st March 2014




Director: Rachel Hoyle
Company secretary: Rachel Hoyle
Registered office: 69 Load Street
Bewdley
Worcestershire
DY12 2AW
Company Registration Number: 07803653 (England and Wales)

NUCLEOTIDE NUTRITION LTD

Abbreviated Balance sheet
As at 31st March 2014

Notes 2014
£
2013
£
Fixed assets
Intangible assets: - 0
Tangible assets: 2 122 0
Total fixed assets: 122 0
Current assets
Stocks: 12,915 13,481
Debtors: 34,968 40,170
Cash at bank and in hand: 848 1,951
Total current assets: 48,731 55,602
Creditors
Creditors: amounts falling due within one year 67,793 59,677
Net current assets (liabilities): ( 19,062 ) ( 4,075 )
Total assets less current liabilities: ( 18,940 ) ( 4,075 )
Total net assets (liabilities): ( 18,940 ) ( 4,075 )

The notes form part of these financial statements

NUCLEOTIDE NUTRITION LTD

Abbreviated Balance sheet
As at 31st March 2014
continued

Notes 2014
£
2013
£
Capital and reserves
Called up share capital: 3 200 100
Profit and Loss account: ( 19,140 ) ( 4,175 )
Total shareholders funds: ( 18,940 ) ( 4,075 )

For the year ending 31 March 2014 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the Financial Reporting Standard for Smaller Entities (effective 2008).

The financial statements were approved by the Board of Directors on 29 November 2014

SIGNED ON BEHALF OF THE BOARD BY:

Name: Rachel Hoyle
Status: Director

The notes form part of these financial statements

NUCLEOTIDE NUTRITION LTD

Notes to the Abbreviated Accounts
for the Period Ended
31st March 2014

  • 1. Accounting policies

    Basis of measurement and preparation of accounts

    The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets and in accordance with the Financial Reporting Standard for Smaller Entities (Effective April 2008)

    Turnover policy

    The turnover shown in the profit and loss account represents revenue recognised by the company in respect of goods and services supplied during the period, exclusive of Value Added Tax and trade discounts.

    Tangible fixed assets depreciation policy

    Depreciation is provided, after taking account of any grants receivable, at the following annual rates in order to write off each asset over its estimated useful life. Computer equipment - 50% on cost.

NUCLEOTIDE NUTRITION LTD

Notes to the Abbreviated Accounts
for the Period Ended
31st March 2014

  • 2. Tangible assets

    Total
    Cost £
    At 01st April 2013: 0
    Additions: 244
    At 31st March 2014: 244
    Depreciation
    At 01st April 2013: 0
    Charge for year: 122
    At 31st March 2014: 122
    Net book value
    At 31st March 2014: 122
    At 31st March 2013: 0

NUCLEOTIDE NUTRITION LTD

Notes to the Abbreviated Accounts
for the Period Ended
31st March 2014

  • 3. Called up share capital

    Allotted, called up and paid

    Previous period 2013
    Class Number of shares Nominal value per share Total
    Ordinary shares: 100 1.00
    1.00
    100
    Total share capital: 100
    Current period 2014
    Class Number of shares Nominal value per share Total
    Ordinary shares: 200 1.00
    1.00
    200
    Total share capital: 200

    During the year 100 ordinary shares of £1 each were issued, allotted and fully paid for cash at par.